Free Trial

Alterity Therapeutics (ATHE) Institutional Ownership

Alterity Therapeutics logo
$3.38 -0.08 (-2.31%)
As of 12:22 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Alterity Therapeutics (NASDAQ:ATHE)

Current
Institutional Ownership
Percentage
2.14%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$163.90K
Number of
Institutional Sellers
(last 12 months)
0
Get ATHE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Alterity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ATHE Institutional Buying and Selling by Quarter

Alterity Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025Point72 Asset Management L.P.32,627$108K0.0%N/A0.373%
2/17/2025BNP Paribas Financial Markets8,790$29K0.0%N/A0.101%
1/15/2025HB Wealth Management LLC31,883$110K0.0%+34.1%0.436%
2/4/2022 Envestnet Asset Management Inc.82,386$59K0.0%N/A0.364%
8/13/2021Renaissance Technologies LLC237,903$309K0.0%+5.9%1.052%
5/21/2021Citadel Advisors LLC65,011$94K0.0%N/A0.288%
5/19/2021Virtu Financial LLC69,905$101K0.0%N/A0.309%
5/18/2021Morgan Stanley627,907$904K0.0%+7.9%2.778%
5/18/2021Citadel Advisors LLC65,011$94K0.0%N/A0.288%
5/13/2021Renaissance Technologies LLC224,690$324K0.0%-30.1%0.994%
(Data available from 1/1/2016 forward)

ATHE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ATHE shares?

During the previous two years, the following institutional investors and hedge funds held shares of Alterity Therapeutics shares: HB Wealth Management LLC ($110K), and Point72 Asset Management L.P. ($108K), BNP Paribas Financial Markets ($29K).Learn more on ATHE's institutional investors.

What percentage of Alterity Therapeutics stock is owned by institutional investors?

2.14% of Alterity Therapeutics stock is owned by institutional investors. Learn more on ATHE's institutional investor holdings.

Which institutional investors have been buying Alterity Therapeutics stock?

The following institutional investors have purchased Alterity Therapeutics stock in the last 24 months: Point72 Asset Management L.P. ($32.63K), BNP Paribas Financial Markets ($8.79K), and HB Wealth Management LLC ($8.10K).

How much institutional buying is happening at Alterity Therapeutics?

Institutional investors have bought a total of 49,517 shares in the last 24 months. This purchase volume represents approximately $163.90K in transactions.



This page (NASDAQ:ATHE) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners